Corrigendum to “Effect of puerarin on P2X3 receptor involved in hyperalgesia after burn injury in the rat” [Brain Res. Bull. 80 (December (6)) (2009) 341–346] (Brain Research Bulletin (2009) 80(6) (341–346), (S0361923009002743), (10.1016/j.brainresbull.2009.08.027));Effect of puerarin on P2X3 receptor involved in hyperalgesia after burn injury in the rat

Brain Research Bulletin

Volumn 80, Issue 6, 2009, Pages 341-346

  Xu, Changshui ^a   Li, Guilin ^a   Gao, Yun ^a   Liu, Shuangmei ^a   Lin, Jiari ^a   Zhang, Jun ^a   Li, Xin ^a   Liu, Han ^a   Liang, Shangdong ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Burn injury pain; Hyperalgesia; P2X3 receptor; Puerarin

Indexed keywords

MESSENGER RNA; PUERARIN; PURINERGIC P2X3 RECEPTOR; ISOFLAVONE DERIVATIVE; PURINERGIC P2 RECEPTOR; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BURN; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HYPERALGESIA; LATENT PERIOD; MALE; NERVE CELL; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL GANGLION; ANIMAL; DISEASE MODEL; HEAT; METABOLISM; PAIN ASSESSMENT; RANDOMIZATION; SPRAGUE DAWLEY RAT; STIMULATION; TIME;

ANIMALS; BURNS; DISEASE MODELS, ANIMAL; GANGLIA, SPINAL; HOT TEMPERATURE; HYPERALGESIA; ISOFLAVONES; MALE; NEURONS; PAIN MEASUREMENT; PHYSICAL STIMULATION; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2; RNA, MESSENGER; TIME FACTORS; VASODILATOR AGENTS;

EID: 70349952173     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2020.07.007     Document Type: Erratum

References (56)

1. Ashburn M.A. Burn pain: the management of procedure-related pain. J. Burn Care Rehab. 16 3 (1995) 365-371
2. Barclay J., Patel S., Dorn G., Wotherspoon G., Moffatt S., Eunson L., Abdel'al S., Natt F., Hall J., Winter J., Bevan S., Wishart W., Fox A., and Ganju P. Functional downregulation of P2X3 receptor subunit in rat sensory neurons reveals a significant role in chronic neuropathic and inflammatory pain. J. Neurosci. 22 (2002) 8139-8147
3. Bodin P., and Burnstock G. Purinergic signalling: ATP release. Neurochem. Res. 26 (2001) 959-969
4. Burgard E.C., Niforatos W., van Biesen T., Lynch K.J., Touma E., Metzger R.E., Kowaluk E.A., and Jarvis M.F. P2X receptor-mediated ionic currents in dorsal root ganglion neurons. J. Neurophysiol. 82 3 (1999) 1590-1598
5. Burnstock G. A unifying purinergic hypothesis for the initiation of pain. Lancet 347 (1996) 1604-1605
6. Burnstock G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol. Rev. 58 1 (2006) 58-86
7. Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev. 87 2 (2007) 659-797
8. Burnstock G. P2X receptors in sensory neurons. Br. J. Anaesth. 84 4 (2000) 476-488
9. Calvert R.C., Thompson C.S., and Burnstock G. ATP release from the human ureter on distension and P2X(3) receptor expression on suburothelial sensory nerves. Purin. Signal 4 4 (2008) 377-381
10. Chen Y., Shu Y., and Zhao Z. Ectopic purinergic sensitivity develops at sites of chronic nerve constriction injury in rat. Neuroreport 10 13 (1999) 2779-2782
11. Chizh B.A., and Illes P. P2X receptors and nociception. Pharmacol. Rev. 53 4 (2001) 553-568
12. Cook S.P., and McCleskey E.W. Cell damage excites nociceptors through release of cytosolic ATP. Pain 95 (2002) 41-47
13. Donnelly-Roberts D., McGaraughty S., Shieh C.C., Honore P., and Jarvis M.F. Painful purinergic receptors. J. Pharmacol. Exp. Ther. 324 (2008) 409-415
14. Dunn P.M., Zhong Y., and Bunstock G. P2X receptors in peripheral neurons. Prog. Neurobiol. 65 2 (2001) 107-134
15. Dussora G., Koerbere H.R., Oaklanderb A.L., Ricec F.L., and Molliverd D.C. Nucleotide signaling and cutaneous mechanisms of pain transduction. Brain Res. Rev. 60 (2009) 24-35
16. Gao Y., Xu C.S., Liang S.D., Zhang A.X., Mu S.N., Wang Y.X., and Wan F. Effect of tetramethylpyrazine on primary afferent transmission mediated receptor in neuropathic pain states by P2X. Brain Res. Bull. 77 (2008) 27-32
17. Gao Q., Yang B., Ye Z.G., Wang J., Bruce I.C., and Xia Q. Opening the calcium-activated potassium channel participates in the cardioprotective effect of puerarin. Eur. J. Pharmacol. 574 (2007) 179-184
18. Grelik C., Bennett G.J., and Ribeiro-da-Silva A. Autonomic fibre sprouting and changes in nociceptive sensory innervation in the rat lower lip skin following chronic constriction injury. Eur. J. Neurosci. 21 (2005) 2475-2487
19. Hamilton S.G., McMahon S.B., and Lewin G.R. Selective activation of nociceptors by P2X receptor agonists in normal and inflamed rat skin. J. Physiol. 534 (2001) 437-445
20. Hamilton S.G., Warburton J., Bhattacharjee A., Ward J., and McMahon S.B. ATP in human skin elicits a dose-related pain response which is potentiated under conditions of hyperalgesia. Brain 123 Part 6 (2000) 1238-1246
21. Hilliges M., Weidner C., Schmelz M., Schmidt R., Ørstavik K., Torebjörk E., and Handwerker H. ATP responses in human C nociceptors. Pain 98 (2002) 59-68
22. Hwang S.W., and Oh U. Current concepts of nociception: nociceptive molecular sensors in sensory neurons. Curr. Opin. Anaesth. 20 (2007) 427-434
23. Jarvis M.F. Contributions of P2X3 homomeric and heteromeric channels to acute and chronic pain. Expert. Opin. Ther. Targets 7 4 (2003) 513-522
24. Jarvis M.F., Burgard E.C., McGaraughty S., Honore P., Lynch K., Brennan T.J., Subieta A., Van Biesen T., Cartmell J., Bianchi B., Niforatos W., Kage K., Yu H., Mikusa J., Wismer C.T., Zhu C.Z., Chu K., Lee C.H., Stewart A.O., Polakowski J., Cox B.F., Kowaluk E., Williams M., Sullivan J., and Faltynek C. A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 17179-17184
25. Kennedy C., Assis T.S., Currie A.J., and Rowan E.G. Crossing the pain barrier: P2 receptors as targets for novel analgesics. J. Physiol. 553 Part 3 (2003) 683-694
26. 3 receptor gating near normal body temperature. Pflug. Arch. 456 (2008) 339-347
27. Liang S.D., Gao Y., Xu C.S., Xu B.H., and Mu S.N. Effect of tetramethylpyrazine on acute nociception mediated by signaling of P2X receptor activation in rat. Brain Res. 995 2 (2004) 247-252
28. Merskrey H. Logic, truth and language in concepts of pain. Qual. Life Res. 3 Suppl. (1994) 69-76
29. 3 purinoceptors in sensory neurons in naive rats and following neuropathic injury. Pain 80 1/2 (1999) 273-282
30. Paukert M., Osteroth R., Geisler H.S., Brandle U., Glowatzki E., Ruppersberg J.P., and Gründer S. Inflammatory mediators potentiate ATP-gated channels through the P2X(3) subunit. J. Biol. Chem. 276 (2001) 21077-21082
31. Raja S.N., Campbell J.N., and Meyer R.A. Evidence for different mechanisms of primary and secondary hyperalgesia following heat injury to the glabrous skin. Brain 107 Part 4 (1984) 1179-1188
32. Richardson P., and Mustard L. The management of pain in the burns unit. Burns (2009) 10.1016/j.burns.2009.03.003
33. Sánchez-Nogueiro J., Marín-GarcíaMustard P., León D., León-Otegui M., Gómez-Villafuertes R., Gualix J., and Miras-Portugal M.T. Axodendritic fibres of mouse cerebellar granule neurons exhibit a diversity of functional P2X receptors. Neurochem. Int. 26 (2009) [Epub ahead of print]PMID: 19560503.
34. Sawynok J. Adenosine and ATP receptors. Handb. Exp. Pharmacol. 177 (2007) 309-328
35. Schneider J.C., Harris N.L., El Shami A., Sheridan R.L., Schulz III J.T., Bilodeau M.L., and Ryan C.M. A descriptive review of neuropathic-like pain after burn injury. J. Burn Care Res. 27 4 (2006) 524-528
36. Shantsila E., Watson T., and Lip G.Y.H. Endothelial progenitor cells in cardiovascular disorders. J. Am. Coll. Cardiol. 49 (2007) 741-752
37. 3 receptor mediates heat hyperalgesia in a rat model of trigeminal neuropathic pain. J. Pain 8 7 (2007) 588-597
38. Sperlagh B., and Vizi E.S. Neuronal synthesis, storage and release of ATP. Semin. Neurosci. 8 (1996) 175-186
39. Steina C., Clarkb J.D., Ohc U., Vaskod M.R., Wilcoxe G.L., Overlande A.C., Vanderahf T.W., and Spencerg R.H. Peripheral mechanisms of pain and analgesia. Brain Res. Rev. 60 (2009) 90-113
40. Summer G.J., Puntillo K.A., Miaskowski C., Green P.G., and Levine J.D. Burn injury pain: the continuing challenge. J. Pain 8 7 (2007) 533-548
41. Tan K.Y., and Wu M. Pharmacological effect and adverse effect analysis on puerarin. China Pharma. 16 3 (2007) 60-61
42. Tsuda M., Hasegawa S., and Inoue K. P2X receptors-mediated cytosolic phospholipase A2 activation in primary afferent sensory neurons contributes to neuropathic pain. J. Neurochem. 103 4 (2007) 1408-1416
43. Tsuda M., Koizumi S., and Inoue K. Role of endogenous ATP at the incision area in a rat model of postoperative pain. Neuroreport 12 (2001) 1701-1704
44. Tsuzuki K., Ase A., Seguela P., Nakatsuka T., Wang C.Y., She J.X., and Gu J.G. TNP-ATP-resistant P2X ionic currents on the central terminals and somata of rat primary sensory neurons. J. Neurophysiol. 89 6 (2003) 3235-3242
45. Uchida H., Matsumoto M., and Ueda H. Profiling of BoNT/C3-reversible gene expression induced by lysophosphatidic acid: ephrinB1 gene up-regulation underlying neuropathic hyperalgesia and allodynia. Neurochem. Int. 54 3-4 (2009) 215-221
46. Ueno S., Tsuda M., Iwanaga T., and Inoue K. Cell type-specific ATP activated responses in rat dorsal root ganglion neurons. Br. J. Pharmacol. 126 2 (1999) 429-436
47. Vizi E.S., Liang S.D., Sperlagh B., Kittel A., and Jurányi Z. Studies on the release and extracellular metabolism of endogenous ATP in rat superior cervical ganglion: support for neurotransmitter role of ATP. Neuroscience 79 (1997) 893-903
48. Vulchanova L., Arvidsson U., Riedl M., Wang J., Buell G., Surprenant A., North R.A., and Elde R. Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry. Proc. Natl. Acad. Sci. U.S.A. 93 15 (1996) 8063-8067
49. 3 receptor involvement in pain states. Mol. Neurobiol. 36 (2007) 165-183
50. Xiao L.Z., Huang Z., Ma S.C., Zen Z., Luo B., Lin X., and Xu X. Study on the effect and mechanism of puerarin on the size of infarction in patients with acute myocardial infarction. Chin. J. Integr. Tradit. Western Med. 24 9 (2004) 790-792
51. Xie R.Q., Du J., and Hao Y.M. Myocardial protection and mechanism of puerarin injection on patients of coronary heart disease with ischemia/reperfusion. Chin. J. Integr. Tradit. Western Med. 23 12 (2003) 895-897
52. Xu X., Zhang S., Zhang L., Yan W., and Zheng X. The neuroprotection of puerarin against cerebral ischemia is associated with the prevention of apoptosis in rats. Planta Med. 71 (2005) 585-591
53. Yeung D.K.Y., Leung S.W.S., Xu Y.C., Vanhoutte P.M., and Man R.Y. Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery. Eur. J. Pharmacol. 552 (2006) 105-111
54. Zhang X., Chen Y., Wang C., and Huang L.Y.M. Neuronal somatic ATP release triggers neuron-satellite glial cell communication in dorsal root ganglia. Proc. Natl. Acad. Sci. U.S.A. 104 23 (2007) 9864-9869
55. Zhang A.X., Xu C.S., Liang S.D., Gao Y., Li G.L., Wei J., Wan F., Liu S.M., and Lin J.R. Role of sodium ferulate in the nociceptive sensory facilitation of neuropathic pain injury mediated by P2X(3) receptor. Neurochem. Int. 53 6-8 (2008) 278-282
56. Zhou J., Fang S.P., Qi Y., Huo H.R., Jiang T.L., and Shi Q. Effect of GeGen decoction on inflammatory media in joint of adjuvant arthritis rats. Chin. J. Exp. Trad. Med. Form. 7 (2001) 29-31